IL4R and breast carcinoma: In order to efficiently deliver miRNAs targeting AQP5 to breast cancer cells, the researchers designed exosomes that express both miRNAs and a peptide targeting the interleukin-4 receptor, which is known to be highly expressed in breast cancer cells.